CLM is constructed from bioactive glass, a resorbable implantable material. Bio2 has successfully applied the proprietary CLM process technology to produce a rigid, osteoconductive material with an interconnected porous structure facilitating the ingrowth and remodeling of healthy bone.
Bio2 is focused on developing a number of CLM-constructed products designed for reconstructive surgery of the extremities.
More articles on devices:
Amedica’s 2014 revenue to hit $22M to $24M — 6 things to know
Sonoma Orthopedic Products receives $12M in financing round
THINK Surgical’s surgical system for THA receives FDA approval
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
